165 related articles for article (PubMed ID: 5305552)
1. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
Bethlem N; Mendes W
Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
[No Abstract] [Full Text] [Related]
2. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Bernard E
Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
[No Abstract] [Full Text] [Related]
3. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
4. Treatment of patients with drug-resistance in economically developed countries.
Crofton J
Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
[No Abstract] [Full Text] [Related]
5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
6. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
7. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
8. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Virchow C
Munch Med Wochenschr; 1969 Aug; 111(35):1717-22. PubMed ID: 4309162
[No Abstract] [Full Text] [Related]
9. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
Rizzo A; Magalhães M; Moura N
Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
[No Abstract] [Full Text] [Related]
10. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Grumbach F
Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
[No Abstract] [Full Text] [Related]
11. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
[No Abstract] [Full Text] [Related]
12. [Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals].
Shimko NP; Maĭovetskaia NS; Severina MV; Alimova LV
Probl Tuberk; 1989; (3):60-4. PubMed ID: 2726714
[No Abstract] [Full Text] [Related]
13. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
[No Abstract] [Full Text] [Related]
14. Duration of application and change of a regimen with secondary drugs.
Oka S; Takase Y; Kato S
Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
[No Abstract] [Full Text] [Related]
15. Management of drug failure cases.
Dingley HB
Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():76-89. PubMed ID: 4145683
[No Abstract] [Full Text] [Related]
16. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
[No Abstract] [Full Text] [Related]
17. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
[No Abstract] [Full Text] [Related]
18. [Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs].
Ibarra JP; Piñeyro J; Trenchi A; Tarallo NH; Lanne de Farriols ME; Cuñarro de Gimeno G; Fernández Latorre I
Hoja Tisiol; 1967; 24(1):5-88. PubMed ID: 4308762
[No Abstract] [Full Text] [Related]
19. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Steininger WJ
Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
[No Abstract] [Full Text] [Related]
20. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
Utkin VV; Rudoĭ NM
Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
